COVID-19 Funded Research

Overview

The NIH Common Fund received $30 Million from the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020 to prevent, prepare for, and respond to coronavirus, domestically or internationally. The Office of Strategic Coordination (OSC), which manages the Common Fund is using these funds to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19). OSC issued immediate funding opportunities in Fiscal Year 2020 for active Common Fund researchers to conduct SARS-CoV-2 and COVID-19 research. Awards issued through these funding opportunities are listed below.

Emergency Competitive Revisions for Research on SARS-COV-2 and COVID-19

The Office of Strategic Coordination (OSC), issued a Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-RM-20-015) to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19).

OSC issued emergency competitive revisions to Common Fund grants and cooperative agreements to support innovative research on COVID-19 or SARS-CoV-2 in areas of research including behavioral/social science, health disparities, and novel therapeutics, that fit within the mission of an emergency response to provide critical expertise, resources or activities. A list of funded projects is available below. Learn more about the awardees and their funded research.

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-RM-20-015
PI Name Institution Name Title Common Fund Program
ASHLEY, EUAN A (contact) 
WHEELER, MATTHEW THOMAS
STANFORD UNIVERSITY Stanford MoTrPAC Bioinformatics Center 

Molecular Transducers of Physical Activity Consortium (MoTrPAC)

BILAL, USAMA DREXEL UNIVERSITY The Health Consequences of Urban Scaling 

NIH Director's Early Independence Award (EIA)

BRAUN, ROBERT E (contact) 
MURRAY, STEPHEN A 
WHITE, JACQUELINE K 
JACKSON LABORATORY The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)

Knockout Mouse Phenotyping Program (KOMP2)

DEKOSKY, BRANDON JAMES UNIVERSITY OF KANSAS LAWRENCE Antibody Display Libraries for Precision Screening of Antibody Immune Responses

NIH Director's Early Independence Award (EIA)

GOLUB, TODD R. (contact) 
SUBRAMANIAN, ARAVIND
BROAD INSTITUTE, INC. Discovering Existing Medicines that Abrogate Cellular Responses to SARS CoV-2 
SANJANA, NEVILLE  NEW YORK GENOME CENTER In situ functional genomics to understand transcriptional regulation

NIH Director's New Innovator Award (NIA)

TULSKY, JAMES A. (contact) 
VOLANDES, ANGELO
DANA-FARBER CANCER INST A Telehealth Advance Care Planning Intervention for COVID-19 in New York City
ZAR, HEATHER JOY (contact) 
NICOL, MARK PATRICK
UNIVERSITY OF CAPE TOWN     COVID-19 and Serological Responses in a South African Birth Cohort Study Global Health
ZHANG, HAICHONG   WORCESTER POLYTECHNIC INSTITUTE Robotic Lung Ultrasound for Triage of COVID-19 Patients in a Resource Limited  NIH Director's Early Independence Award (EIA)

This page last reviewed on September 28, 2020